跳轉至內容
Merck
全部照片(1)

重要文件

G001635

HPLC Analysis of 3-Methylpyrazole and 4-Methylpyrazole in Urine on Discovery® C18 after SPE using Discovery® DSC-SCX

application for SPE, application for HPLC

登入查看組織和合約定價


About This Item

技術

HPLC: suitable
solid phase extraction (SPE): suitable

測試參數

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: urine spiked with 3- and 4-methylpyrazole at 1 mg/mL
SPE tube/cartridge: Discovery DSC-SCX, 500 mg/3 mL (52686-U)
condition: 2 mL methanol; 2 mL DI water
sample addition: 1 mL
washing: 2 mL DI water
elution: 2 mL 5% methanol in 250 mM potassium phosphate buffer, pH 7.4
column: Discovery C18, 15 cm × 4.6 mm, 5 μm preceded by a 2 cm guard column and 0.5 μm frit filter (504955)
mobile phase: MeOH:5 mM phosphate buffer, pH 6 (20:80)
flow rate: 1 mL/min
column temp.: 30 °C
detector: UV, 220 nm
injection: 25 μL, dilute urine extract

適合性

application for HPLC
application for SPE

應用

forensics and toxicology

法律資訊

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

描述

    3-Methylpyrazole

從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務